[go: up one dir, main page]

EP3836803A4 - Stability of vitamin d in beta-hydroxy- beta-methylbutyrate (hmb) - Google Patents

Stability of vitamin d in beta-hydroxy- beta-methylbutyrate (hmb) Download PDF

Info

Publication number
EP3836803A4
EP3836803A4 EP19935709.6A EP19935709A EP3836803A4 EP 3836803 A4 EP3836803 A4 EP 3836803A4 EP 19935709 A EP19935709 A EP 19935709A EP 3836803 A4 EP3836803 A4 EP 3836803A4
Authority
EP
European Patent Office
Prior art keywords
beta
hmb
methylbutyrate
vitamin
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19935709.6A
Other languages
German (de)
French (fr)
Other versions
EP3836803A1 (en
Inventor
John Rathmacher
Martin Purpura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolic Technologies LLC
Original Assignee
Metabolic Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Technologies LLC filed Critical Metabolic Technologies LLC
Priority claimed from PCT/US2019/038948 external-priority patent/WO2020263229A1/en
Publication of EP3836803A1 publication Critical patent/EP3836803A1/en
Publication of EP3836803A4 publication Critical patent/EP3836803A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
EP19935709.6A 2018-06-25 2019-06-25 Stability of vitamin d in beta-hydroxy- beta-methylbutyrate (hmb) Pending EP3836803A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862689305P 2018-06-25 2018-06-25
PCT/US2019/038948 WO2020263229A1 (en) 2019-06-25 2019-06-25 STABILITY OF VITAMIN D IN β-HYDROXY- β-METHYLBUTYRATE (HMB)

Publications (2)

Publication Number Publication Date
EP3836803A1 EP3836803A1 (en) 2021-06-23
EP3836803A4 true EP3836803A4 (en) 2022-07-20

Family

ID=75293630

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19935709.6A Pending EP3836803A4 (en) 2018-06-25 2019-06-25 Stability of vitamin d in beta-hydroxy- beta-methylbutyrate (hmb)

Country Status (3)

Country Link
EP (1) EP3836803A4 (en)
BR (1) BR112020026621A2 (en)
CO (1) CO2021000763A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060019933A1 (en) * 2004-07-22 2006-01-26 David Boardman Process for preparing stabilized vitamin D
US20140037797A1 (en) * 2011-02-07 2014-02-06 Abbott Laboratories Nutritional products comprising beta-hydroxy-beta-methylbutyrate
WO2015137965A1 (en) * 2014-03-14 2015-09-17 Metabolic Technologies, Inc. Liquids and foodstuffs containing beta-hydroxy-beta-methylbutyrate (hmb) in free acid form

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060019933A1 (en) * 2004-07-22 2006-01-26 David Boardman Process for preparing stabilized vitamin D
US20140037797A1 (en) * 2011-02-07 2014-02-06 Abbott Laboratories Nutritional products comprising beta-hydroxy-beta-methylbutyrate
WO2015137965A1 (en) * 2014-03-14 2015-09-17 Metabolic Technologies, Inc. Liquids and foodstuffs containing beta-hydroxy-beta-methylbutyrate (hmb) in free acid form

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020263229A1 *

Also Published As

Publication number Publication date
EP3836803A1 (en) 2021-06-23
BR112020026621A2 (en) 2021-03-30
CO2021000763A2 (en) 2021-04-08

Similar Documents

Publication Publication Date Title
EP3866771A4 (en) High-potency vitamin c topical formulations
EP3658557A4 (en) Tyk2 inhibitors and uses thereof
EP3582755A4 (en) Formulations
EP3538078A4 (en) Formulations for efficient delivery of cannabinoids
AU2017435893B2 (en) Methods for the administration of certain VMAT2 inhibitors
EP3551204A4 (en) Systems and methods for extraction of natural products
EP3731832A4 (en) Cannabidiol dosage form
EP3704224A4 (en) Nutritive compositions and methods related thereto
EP3405262A4 (en) Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (hmb) for modulating autophagy and lipophagy
EP3472176A4 (en) Utility of (+) epicatechin and their analogs
EP3399996A4 (en) Methods of administering hepcidin
EP3191091A4 (en) Dietary emulsion formulations and methods for using the same
EP3528787A4 (en) Pharmaceutical formulations and methods of making the same
EP3244900A4 (en) Pharmaceutical formulations comprising high purity cangrelor and methods for preparing and using the same
EP3595693A4 (en) Cannabinoid formulations and dosage
EP3526210A4 (en) Bromodomain inhibitors
EP3746080A4 (en) Pharmaceutical formulations
EP3337463A4 (en) Pharmaceutical formulations
EP3554508A4 (en) Pharmaceutical formulations of suvorexant
EP3506947A4 (en) Pharmaceutical formulations of regadenoson
EP3677151A4 (en) Dining chair for children
EP3497080A4 (en) Pharmaceutical formulations and their use
EP3609896A4 (en) Bromodomain inhibitors
EP3526197A4 (en) Bromodomain inhibitors
EP3612185A4 (en) Pharmaceutical compositions comprising poh derivatives and methods of use

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210125

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20220622

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 65/00 20060101ALI20220615BHEP

Ipc: A61K 31/59 20060101ALI20220615BHEP

Ipc: A61K 31/19 20060101ALI20220615BHEP

Ipc: A23L 33/00 20160101ALI20220615BHEP

Ipc: A23L 33/155 20160101AFI20220615BHEP

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: METABOLIC TECHNOLOGIES, LLC